Effects of terbutaline on NGF formation in allergic inflammation of the rat

British Journal of Pharmacology

Volumn 133, Issue 1, 2001, Pages 186-192

  Amann, R ^a   Peskar, B A ^a   Schuligoi, R ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Allergic inflammation; Nerve growth factor; Terbutaline

Indexed keywords

ANTIGEN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; MESSENGER RNA; NERVE GROWTH FACTOR; TERBUTALINE; VASOACTIVE AGENT;

ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHIL; IMMUNE RESPONSE; IMMUNOREACTIVITY; INFLAMMATION; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; SENSITIZATION; SKIN EDEMA;

EID: 0034992625     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704060     Document Type: Article

References (44)

1. Beta 2-adrenoceptors mediate a reduction in endothelial permeability in vitro
2. Nerve growth factor: A neurotrophin with activity on cells of the immune system
3. 1 receptor antagonist SR140333 prevents the increase of NGF in rat paw skin induced by substance P or neurogenic inflammation
4. Inhibition of carrageenan-induced oedema by indomethacin or sodium salicylate does not prevent the increase of nerve growth factor in the rat hind paw
5. The effect of selective phosphodiesterase 3 and 4 isoenzyme inhibitors and established anti-asthma drugs on inflammatory cell activation
6. Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils
7. Anti-inflammatory effect of beta 2-agonists: Inhibition of TNF-alpha release from human mast cells
8. Salmeterol reduces early- and late-phase plasma leakage and leukocyte adhesion in rat airways
9. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma
10. Inhibition of neutrophil and eosinophil adhesion to venules of rat trachea by beta 2-adrenergic agonist formoterol
11. Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma
12. Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms
13. Functional desensitization of beta agonist responses in human lung mast cells
14. Time courses of the anti-anaphylactic and anti-inflammatory effects of dexamethasone in the rat and mouse
15. Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects
16. Sensitisation of visceral afferents by nerve growth factor in the adult rat
17. The role of nerve growth factor in a model of visceral inflammation
18. Induction of tachykinin gene and peptide expression in guinea pig nodose primary afferent neurons by allergic airway inflammation
19. Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics
20. Hyperinnervation of the airways in transgenic mice overexpressing nerve growth factor
21. Nerve growth factor-induced phenotypic switch in guinea pig airway sensory neurons
22. Human CD4+ T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors
23. Mast cells synthesize, store, and release nerve growth factor
24. NGF as a mediator of inflammatory pain
25. Electrophysiological effects of tachykinins and capsaicin on guinea-pig bronchial parasympathetic ganglion neurones
26. Nonbronchodilator effects of inhaled beta 2 agonists. Greater protection against adenosine monophosphate- than methacholine-induced bronchoconstriction in asthma
27. Neurotrophins and cytokines-intermediaries between the immune and nervous systems
28. The effect of salmeterol and salbutamol on mediator release and skin responses in immediate and late phase allergic cutaneous reactions
29. Intranasal salmeterol inhibits allergen-induced vascular permeability but not mast cell activation or cellular infiltration
30. The long-acting beta2-agonist salmeterol xinafoate: Effects on airway inflammation in asthma
31. Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia
32. Nerve growth factor expression and release in allergic inflammatory disease of the upper airways
33. Effect of colchicine on nerve growth factor-induced leukocyte accumulation and thermal hyperalgesia in the rat
34. Neurotrophins and hyperalgesia
35. Histamine in tissue: Determination by high performance liquid chromatography after condensation with o-phtal-dialdehyde
36. Nerve growth factor is preformed in and activates human peripheral blood eosinophils
37. Antiallergic actions of high topical doses of terbutaline in human nasal airways
38. Nerve growth factor is an autocrine survival factor for memory B lymphocytes
39. Expression of neurotrophic factors and neuropeptide receptors by Langerhans cells and the Langerhans cell-like cell line XS52: Further support for a functional relationship between Langerhans cells and epidermal nerves
40. Expression and modulation of nerve growth factor in murine keratinocytes (PAM 212)
41. Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: A randomized, placebo controlled trial
42. Release of nerve growth factor from cultured aortic smooth-muscle cells
43. Secretion of a nerve growth factor by primary chick fibroblast cultures
44. Proposals of the Committee for Research and Ethical Issues of IASP